The Aurora EV ICD system provides anti-tachycardia pacing, cardioversion and defibrillation therapies through a lead placed under the breastbone, outside of the heart and veins.
Medtronic’s Aurora EV ICD system will be the first extravascular implantable cardioverter defibrillator available in the US.
On 23 October, the US Food and Drug Administration approved Aurora to provide defibrillation shocks, anti-tachycardia pacing (ATP), and...
Create an account to read this article
Already a subscriber?
The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.
Medicare beneficiaries with tricuspid regurgitation will now have access to an innovative treatment from Abbott that offers a minimally invasive alternative to open-heart surgery.
The US FDA posted eight device-related warning letters in June, touching on industry sectors from urinalysis test strips to ophthalmic devices.
